Barclays’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.57M | Buy |
|
|||||
|
2025
Q2 | $5.89M | Buy |
|
|||||
|
2025
Q1 | $3.13M | Sell |
|
|||||
|
2024
Q4 | $4.28M | Sell |
|
|||||
|
2024
Q3 | $4.6M | Buy |
|
|||||
|
2024
Q2 | $2.95M | Buy |
|
|||||
|
2024
Q1 | $3.13M | Sell |
|
|||||
|
2023
Q4 | $5.88M | Buy |
|
|||||
|
2023
Q3 | $4.27M | Buy |
|
|||||
|
2023
Q2 | $1.41M | Buy |
|
|||||
|
2023
Q1 | $1.25M | Sell |
|
|||||
|
2022
Q4 | $2.29M | Buy |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $166K | Sell |
|
|||||
|
2022
Q1 | $165K | Buy |
|